LOXL2 and melanoma: Further functional analysis showed that poorly differentiated BRAFi-resistant melanoma cells also display a CAF-like phenotype characterized by the upregulation of typical myofibroblast and pro-fibrotic markers, including α-SMA, caveolin 1, MLC2, TAGLN2, FAPα and LOXL2 [13].